此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting

2026年11月12日 更新者:Central Ohio Urology Group

A Single-center Study of Robotic Prostatectomy Surgeries Performed Using the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in an Ambulatory Surgical Center Setting

A Single-center Study of Robotic Prostatectomy Surgeries Performed using the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in an Ambulatory Surgical Center Setting

研究概览

地位

招聘中

详细说明

The purpose of this study is to collect and analyze clinical, procedural/operational and economics data on the commercial use of the Hugo™ Robotic Assisted Surgery (RAS) System in prostatectomy patients treated in an ASC setting at the Central Ohio Urology Group (COUG).

This data will address a current evidence gap by providing insights into clinical outcomes, learning curve, procedural efficiency, patient recovery, and economic metrics at COUG. The study also aims to demonstrate the feasibility and benefits of performing RAS in an ASC setting, thereby advancing the adoption of Hugo™ RAS in this growing care setting.

研究类型

观察性的

注册 (估计的)

100

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

男性

取样方法

非概率样本

研究人群

All male patients aged 18 years or older diagnosed with prostate cancer who are treated with robotic surgery using the Hugo™ RAS System.

描述

Inclusion Criteria:

  • Subjects (male) ≥ 18 years old
  • Subject has been indicated for a radical prostatectomy surgical procedure
  • Subject is able to be treated with robotic surgery
  • Subject is willing to participate and consents to participate, as documented by signed Institutional Review Board (IRB) approved informed consent form

Exclusion Criteria:

  • Contraindicated for treatment with the Hugo™ RAS System in accordance with the commercial Instructions for Use and local regulations
  • Subject is participating in another clinical investigation at the time of enrollment or has planned participation in another clinical investigation at any time during this study that may influence the results of this study

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:CASE_ONLY
  • 时间观点:PROSPECTIVE

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence of Perioperative Complications
大体时间:From first incision through skin closure

Number of participants experiencing an intraoperative complication following robot-assisted radical prostatectomy performed using the Hugo™ RAS System. Complications will be classified according to institutional standards and summarized by severity.

From first incision through skin closure
Incidence of Postoperative Complications
大体时间:From the end of the procedure through 90 days post-procedure

Number of participants experiencing a postoperative complication following robot-assisted radical prostatectomy performed using the Hugo™ RAS System. Complications will be classified according to institutional standards and summarized by severity.

From the end of the procedure through 90 days post-procedure
Conversion to Alternative Surgical Approach
大体时间:From first incision through skin closure

Number of procedures converted from robotic-assisted surgery using the Hugo™ RAS System to an open, laparoscopic, or other surgical approach.

From first incision through skin closure

其他结果措施

结果测量
措施说明
大体时间
Operative Time
大体时间:Up to 340 minutes

Operative time shall be collected through the length of the procedure. Assessed on the day of surgery

Up to 340 minutes
Operating Room Turnover
大体时间:From completion of the procedure (skin closure) until operating room readiness for the subsequent case, assessed on the day of surgery

Time from completion of a procedure until the operating room is ready for the subsequent case

From completion of the procedure (skin closure) until operating room readiness for the subsequent case, assessed on the day of surgery
Total Procedure Cost
大体时间:From the date of surgery through completion of associated ambulatory surgical center billing

Total direct Ambulatory Surgery Center cost associated with robot-assisted radical prostatectomy performed using the Hugo™ RAS System

From the date of surgery through completion of associated ambulatory surgical center billing
Surgeon Learning Curve
大体时间:From the surgeon's first patient procedure through the last patient procedure

Change in operative time across sequential prostatectomy cases performed using the Hugo™ RAS System as a measure of surgeon proficiency acquisition

From the surgeon's first patient procedure through the last patient procedure

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

合作者

调查人员

  • 首席研究员:Ronney Abaza, MD、Central Ohio Urology Group

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年10月27日

初级完成 (估计的)

2028年9月30日

研究完成 (估计的)

2028年9月30日

研究注册日期

首次提交

2026年6月9日

首先提交符合 QC 标准的

2026年10月9日

首次发布 (实际的)

2026年10月15日

研究记录更新

最后更新发布 (实际的)

2026年11月13日

上次提交的符合 QC 标准的更新

2026年11月12日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅